In this case, the KMT2A-AFF1 fusion and all somatic gene mutations present in the relapse ALL sample were shared in the AML sample, but the AML sample had also acquired several new genetic alterations, some in genes more commonly mutated in myeloid diseases (e.g., TET1 and TET2). This evidence concerns the gene AFF1 and acute lymphoblastic leukemia.